MPI Research, a contract research organisation (CRO) based in Mattawan, Michigan, has implemented a Gyrolab xP workstation from Gyros into its time-critical project workflows.
Alan Breau, vice president for bioanalytical/analytical services said: 'Data from immunoassays underpin many critical decisions within complex project workflows.
'Our goal as a CRO is to deliver high-quality results as rapidly and cost-effectively as possible to our clients in the biopharmaceutical industry.
'The automated nanolitre-scale immunoassay platform from Gyros enables us to quickly develop project-specific biomarker, pharmacokinetic (PK) and immunogenicity assays and to easily transfer the running of established assays, thereby freeing staff for other tasks.
'The ability to work with such small volumes ensures that we maximise the number of assays that can be performed on samples that are often in limited supply.
'We believe this investment will significantly impact the cost-efficiency as well as the turnaround time of our preclinical and clinical studies,' he added.
